Evidence map›Paper›PMID 39967724›Full record

ReviewJournal of public health in Africa2025

Asymptomatic testing people for SARS-CoV-2 in healthcare facilities: A systematic review.

Olabisi A Oduwole, Glory Bassey, Grace Esebanmen, Samuel Shoyinka, Johnsolomon Ohenhen, Elise Cogo, Nicholas Henschke, Eleanor Ochodo, Martin M Meremikwu

Abstract readReview
In one paragraph

Review in Journal of public health in Africa, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Olabisi A OduwoleDepartment of Medical Microbiology and Parasitology, Faculty of Medical Laboratory Science, Achievers University, Owo, Nigeria.ORCID https://orcid.org/0000-0003-3221-1139
Glory BasseyDepartment of Paediatrics, University of Calabar Teaching Hospital, Calabar, Nigeria.ORCID https://orcid.org/0000-0002-2532-674X
Grace EsebanmenNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.ORCID https://orcid.org/0000-0002-4352-7537
Samuel ShoyinkaDepartment of Medical Microbiology and Parasitology, Faculty of Medical Laboratory Science, Achievers University, Owo, Nigeria.ORCID https://orcid.org/0009-0004-7408-0223
Johnsolomon OhenhenDepartment of Medical Microbiology and Parasitology, Faculty of Medical Laboratory Science, Achievers University, Owo, Nigeria.ORCID https://orcid.org/0009-0006-5736-5782
Elise CogoCochrane Response, London, United Kingdom.ORCID https://orcid.org/0000-0003-2480-3652
Nicholas HenschkeCochrane Response, London, United Kingdom.ORCID https://orcid.org/0000-0002-9624-2519
Eleanor OchodoCentre for Global Health Research, Kenya Medical Research Institute, Kenya, Kenya.ORCID https://orcid.org/0000-0002-7951-3030
Martin M MeremikwuCochrane Nigeria, Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria.ORCID https://orcid.org/0000-0002-6144-9413

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Asymptomatic testing involves the process whereby individuals who do not show symptoms of COVID-19 are tested for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection using any of the available laboratory test techniques. Aim: To evaluate the effectiveness of testing asymptomatic individuals visiting, living or working in healthcare facilities in reducing SARS-CoV-2 viral infections. Setting: Healthcare databases. Method: Electronic databases were searched and limited to English language and studies published 2020 to 02 September 2022. Following the methods for rapid systematic reviews, data were analysed using a fixed effect model, and results of the effect estimate were reported as odds ratios (OR) with their confidence intervals (CI) (95% CI). Results: Databases' searches yielded 3065 articles after deduplication and 3 studies by searching reference lists of included articles. After screening abstracts and full text articles, 3 cohort studies were included, each with serious risk of bias. Very low certainty evidence shows a decrease in occurrence of SARS-CoV-2 infections in the asymptomatic testing group among patients going for index surgery (OR: 0.05, 95 % CI: 0.00-0.82; 501 participants; 1 study) and among long term care facility staff (OR: 0.31, 95 % CI: 0.18-0.52; 3457 participants; 2 studies, Conclusion: There is limited quality evidence to support asymptomatic testing of individuals for SARS-CoV-2 in the prevention of virus transmission in health care settings. Contribution: In the event of a future pandemic, this review offers current evidence on the potential effects of asymptomatic testing.

Indexed as

asymptomatic COVID-19asymptomatic diagnosisasymptomatic SARS-CoV-2asymptomatic screeningasymptomatic testingCOVID-19 test

Identifiers

PMID39967724
PMCPMC11830837

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.